Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for CBSC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 170.44M
March 31, 2026 165.44M
December 31, 2025 165.44M
September 30, 2025 165.44M
June 30, 2025 164.02M
March 31, 2025 162.17M
December 31, 2024 161.37M
September 30, 2024 158.01M
June 30, 2024 156.78M
March 31, 2024 154.27M
December 31, 2023 141.55M
September 30, 2023 139.37M
June 30, 2023 132.22M
March 31, 2023 129.52M
December 31, 2022 123.03M
September 30, 2022 112.24M
June 30, 2022 112.60M
March 31, 2022 112.24M
December 31, 2021 102.32M
September 30, 2021 82.04M
Date Value
June 30, 2021 82.36M
March 31, 2021 82.04M
December 31, 2020 79.82M
September 30, 2020 79.45M
June 30, 2020 128.39M
March 31, 2020 58.59M
June 30, 2019 58.59M
March 31, 2019 58.59M
December 31, 2018 58.59M
September 30, 2018 58.59M
June 30, 2018 58.59M
March 31, 2018 58.59M
December 31, 2017 58.59M
September 30, 2017 57.12M
June 30, 2017 57.11M
March 31, 2017 57.11M
December 31, 2016 57.11M
September 30, 2016 57.11M
June 30, 2016 57.11M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Vyome Holdings, Inc. 7.018M
Abbott Laboratories 1.730B
AngioDynamics, Inc. 41.70M
Alphatec Holdings, Inc. 152.68M
AtriCure, Inc. 50.86M